ACI 3rd Annual Summit on Life Sciences IP Due Diligence

David J. Dykeman, patent attorney and co-chair of Greenberg Traurig, LLP’s global Life Sciences & Medical Technology Group and Boston Intellectual Property & Technology (IP) Group, will present at the American Conference Institute’s (ACI) 3rd Annual Summit on Life Sciences IP Due Diligence, Nov. 14-15, 2019 in Boston, MA. From 10:45 a.m. – 12:00 p.m. on Nov. 14, Dykeman will moderate the panel, “Avoiding Missteps During the Chain of Title Review: Understanding Ownership Rules,” which will address patent ownership questions related to the valuation of proprietary life sciences technology.